Nikunj Patel

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial

Howard A. Burris, Takuji Okusaka, Arndt Vogel et al. · The Lancet Oncology · 2024 · 115 citations

Patient-reported Outcomes, Gastrointestinal Oncology, Medicine +7

The asymmetry effect of industrialization, financial development and globalization on CO2 emissions in India

Nikunj Patel, Dhyani Mehta · International Journal of Thermofluids · 2023 · 76 citations · Full text

Economics, Carbon Emission Trading, Engineering +15

The impact of economic growth, trade openness and manufacturing on CO2 emissions in India: an autoregressive distributive lag (ARDL) bounds test approach

Yaswanth Karedla, Rohit Mishra, Nikunj Patel · Journal of Economics Finance and Administrative Science · 2021 · 64 citations · Full text

Engineering, Economic Development, Greenhouse Gas Emission +20

PD-L1 expression, patterns of progression and patient-reported outcomes (PROs) with durvalumab plus platinum-etoposide in ES-SCLC: Results from CASPIAN

Luis Paz‐Ares, Jonathan W. Goldman, Marina Chiara Garassino et al. · Annals of Oncology · 2019 · 52 citations · Full text

Translational Medicine, Patient-reported Outcomes, Pd-l1 Expression +7

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study

Jonathan W. Goldman, Marina Chiara Garassino, Yuanbin Chen et al. · Lung Cancer · 2020 · 52 citations · Full text